<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>dmt.clinic</title>
    <link>https://dmt.clinic</link>
    <description>Educational research reference for DMT — not a clinic or treatment service</description>
    <language>en-US</language>
    <atom:link href="https://dmt.clinic/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Psychedelic-Assisted Therapy in 2026: What&apos;s Legal, What&apos;s Coming</title>
      <link>https://dmt.clinic/blog/2026-05-30-psychedelic-assisted-therapy-2026-whats-legal-whats-coming/</link>
      <guid isPermaLink="true">https://dmt.clinic/blog/2026-05-30-psychedelic-assisted-therapy-2026-whats-legal-whats-coming/</guid>
      <pubDate>Sat, 30 May 2026 00:00:00 GMT</pubDate>
      <description>A plain-English overview of which psychedelic therapies are currently legal in the US, what&apos;s in clinical trials, and what patients and clinicians need to know.</description>
    </item>
    <item>
      <title>Ketamine vs Other Psychedelics: What Patients Should Know</title>
      <link>https://dmt.clinic/blog/2026-05-29-ketamine-vs-other-psychedelics-what-patients-should-know/</link>
      <guid isPermaLink="true">https://dmt.clinic/blog/2026-05-29-ketamine-vs-other-psychedelics-what-patients-should-know/</guid>
      <pubDate>Fri, 29 May 2026 00:00:00 GMT</pubDate>
      <description>How ketamine compares to psilocybin, MDMA, and DMT in mechanism, legal status, clinical use, and what that means for someone considering treatment.</description>
    </item>
    <item>
      <title>FDA Psychedelic Trials Update: Where MDMA and Psilocybin Stand in 2026</title>
      <link>https://dmt.clinic/blog/2026-05-28-fda-psychedelic-trials-update-mdma-psilocybin-2026/</link>
      <guid isPermaLink="true">https://dmt.clinic/blog/2026-05-28-fda-psychedelic-trials-update-mdma-psilocybin-2026/</guid>
      <pubDate>Thu, 28 May 2026 00:00:00 GMT</pubDate>
      <description>A current look at the FDA review status of MDMA and psilocybin therapies, what the Complete Response Letter means, and what timelines look realistic in 2026.</description>
    </item>
  </channel>
</rss>